ISRCTN63659091
Completed
未知
Study of immediate versus deferred antiretroviral therapy in human immunodeficiency virus-associated tuberculous meningitis
niversity of Oxford (UK)0 sites222 target enrollmentJuly 22, 2005
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- HIV-associated tuberculous meningitis
- Sponsor
- niversity of Oxford (UK)
- Enrollment
- 222
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
2011 results in: https://www.ncbi.nlm.nih.gov/pubmed/21596680
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients aged 15 or over
- •2\. HIV seropositive
- •3\. Anti\-retroviral naive
- •4\. Presenting with tuberculous meningitis
Exclusion Criteria
- •1\. Positive Cerebrospinal Fluid (CSF) Gram or India ink stain
- •2\. Known or suspected pregnancy
- •3\. Anti\-tuberculous treatment eight to 30 days immediately prior to recruitment
- •4\. Previous antiretroviral therapy
- •5\. Laboratory contraindications to anti\-retroviral or anti\-tuberculous therapy
- •6\. Lack of consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Immediate versus deferred anti-HIV-therapy in patients presenting acute AIDS-defining events.Patients in late stage of HIV-infection, treatment naive or without ART for the last 6 month with an acute AIDS-defining illness, namely PCP or TE.MedDRA version: 18.0Level: LLTClassification code 10001509Term: AIDSSystem Organ Class: 100000004862Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]EUCTR2010-022413-26-DEniversity Medical Center Hamburg-Eppendorf
Completed
Phase 4
Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining EventsHIV-InfectionNCT01417949Universitätsklinikum Hamburg-Eppendorf61
Terminated
Not Applicable
Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) TreatmentHIVAIDSTuberculosisNCT00737724Instituto Nacional de Enfermedades Respiratorias63
Completed
Phase 2
Early ART to Limit Infection and Establishment of ReservoirHIV-1 InfectionNCT02859558Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections195
Active, not recruiting
Phase 1
Impact of extremely early antiretroviral therapy to reduce VIral REservoir and induce functional CURE of HIV-1 infection. A pilot comparative study.HIV-1 infectionTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2015-000251-24-ESFundacio Privada Clinic per a la Recerca Biomedica15